QUOTE AND NEWS
The Economic Times  6 hrs ago  Comment 
"In fact this morning it has announced Rs 8 dividend including Rs 60 special dividend and it gives you more than 7% dividend yield "
The Hindu Business Line  8 hrs ago  Comment 
Akzo Nobel India Ltd has said that the board of directors of the company at its meeting held on May 20 recommended a dividend of Rs 20 a share plus a special dividend of Rs 60 per equity share for...
The Economic Times  May 20  Comment 
Paint maker Akzo Nobel India today reported a net profit of Rs 62.50 crore for the quarter ended March 31, 2013.
MarketWatch  Apr 18  Comment 
European stock markets struggled for direction at the open on Thursday, after posting a four-day losing streak the prior day when most major bourses closed at 2013 lows. Later in the day, a Spanish bond auction and U.S. jobless claims are likely...
Bloomberg  Feb 21  Comment 
Akzo Nobel NV had its biggest two- day decline for more than four years in Amsterdam after Chief Executive Officer Ton Buechner’s long-awaited management blueprint for the chemical and paint company failed to impress.
The Economic Times  Feb 14  Comment 
Paints and coatings maker Akzo Nobel India today reported a net profit of Rs 50.63 crore for the quarter ended December 31, 2012.
Wall Street Journal  Dec 14  Comment 
Returning to work after being treated for exhaustion, Akzo Nobel's Tom Buchner wrapped up the sale of the company's architectural-coatings business.




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Based in the Netherlands, Akzo Nobel N.V.is a Global Fortune 500 chemicals company, producing a vast array of goods such as human and animal pharmaceuticals, paints, stains, hospital supplies, and other products. The company operates three business segments: Coatings, Chemicals, and Pharma. The Coatings segment makes decorative, industrial and protective coatings, as well as industrial finishes, car refinishes, and other industrial products. The Chemicals segment produces specialty, functional, and commodity chemicals. Its products include pulp and paper, surfactants, polymers and base chemicals, as well as high-quality salts. The Pharma segment is engaged in research, development, manufacturing, sales and services in strategic areas of human and animal healthcare. The Pharma business is named as Organon Biosciences (OBS). This segment comprises two units: Organon, which makes prescription medicines and produces complex active pharmaceutical ingredients and Intervet, which manufactures veterinary products.

Comparison to Competitors


References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki